Gynecologic Oncology

Molecular and Cytokinetic Pretreatment Risk Assessment in Endometrial Carcinoma
pp. 1-7(7)
Authors: Silverman M.B.; Roche P.C.; Kho R.M.; Keeney G.L.; Li H.; Podratz K.C.

Molecular Characteristics of Cancers: The Way of the Future?
pp. 8-10(3)
Author: Mutch D.G.

Apoptosis, bcl-2 Expression, and Proliferation in Benign and Malignant Endometrial Epithelium: An Approach Using Multiparameter Flow Cytometry
pp. 11-17(7)
Authors: Morsi H.M.; Leers M.P.G.; Radespiel-Tröger M.; Björklund V.; Kabarity H.E.; Nap M.; Jäger W.

Atypical Clustering of Gynecologic Malignancies: A Family Study Including Molecular Analysis of Candidate Genes
pp. 18-25(8)
Authors: Cohn D.E.; Babb S.; Whelan A.J.; Mutch D.G.; Herzog T.J.; Rader J.S.; Elbendary A.; Goodfellow P.J.

Expression of Thymidine Phosphorylase in Epithelial Ovarian Cancer: Correlation with Angiogenesis, Apoptosis, and Ultrasound-Derived Peak Systolic Velocity
pp. 26-34(9)
Authors: Hata K.; Fujiwaki R.; Maede Y.; Nakayama K.; Fukumoto M.; Miyazaki K.

Expression of Carbohydrate Antigens in Advanced-Stage Ovarian Carcinomas and Their Metastases—A Clinicopathologic Study
pp. 35-43(9)
Authors: Davidson B.; Gotlieb W.H.; Ben-Baruch G.; Kopolovic J.; Goldberg I.; Nesland J.M.; Berner A.; Bjåmer A.; Bryne M.

Whole-Body PET with (Fluorine-18)-2-deoxyglucose for Detecting Recurrent Primary Serous Peritoneal Carcinoma: An Initial Report
pp. 44-47(4)
Authors: Wang P-H.; Liu R-S.; Li Y.F.; Ng H-T.; Yuan C-C.

Efficacy and Hematologic Toxicity of Salvage Chemotherapy Following Stem Cell-Supported High-Dose Chemotherapy in Women with Recurrent Ovarian Cancer
pp. 48-54(7)
Authors: Cook S.; Penson R.; Duska L.; Nikrui N.; Goodman A.; Fuller A.; Seiden M.

The Outcome of Stage I–II Clinically and Surgically Staged Papillary Serous and Clear Cell Endometrial Cancers When Compared with Endometrioid Carcinoma
pp. 55-65(11)
Authors: Cirisano F.D.; Robboy S.J.; Dodge R.K.; Bentley R.C.; Krigman H.R.; Synan I.S.; Soper J.T.; Clarke-Pearson D.L.

Results of Radical Radiotherapy for Recurrent Endometrial Cancer
pp. 66-72(7)
Authors: Wylie J.; Irwin C.; Pintilie M.; Levin W.; Manchul L.; Milosevic M.; Fyles A.

Sexual Dysfunction Following Vulvectomy
pp. 73-77(5)
Authors: Green M.S.; Naumann R.W.; Elliot M.; Hall J.B.; Higgins R.V.; Grigsby J.H.

Combined Transvaginal B-Mode and Color Doppler Sonography for Differential Diagnosis of Ovarian Tumors: Results of a Multivariate Logistic Regression Analysis
pp. 78-86(9)
Authors: Schelling M.; Braun M.; Kuhn W.; Bogner G.; Gruber R.; Gnirs J.; Schneider K.T.; Ulm K.; Rutke S.; Staudach A.

Technical Development and Results of Left Extraperitoneal Laparoscopic Paraaortic Lymphadenectomy for Cervical Cancer
pp. 87-92(6)
Authors: Dargent D.; Ansquer Y.; Mathevet P.

Inguinal Node Status by Ultrasound in Vulva Cancer
pp. 93-96(4)
Authors: Abang Mohammed D.K.; Uberoi R.; de B. Lopes A.; Monaghan J.M.

Rare Activation of the TCF/-Catenin Pathway in Ovarian Cancer
pp. 97-104(8)
Authors: Furlong M.T.; Morin P.J.

ras Gene Activation and Infrequent Mutation in Papillary Serous Carcinoma of the Peritoneum
pp. 105-111(7)
Authors: Garrett A.P.; Ng S-W.; Muto M.G.; Welch W.R.; Bell D.A.; Berkowitz R.S.; Mok S.C.

Phase II Evaluation of 24-h Continuous Infusion Topotecan in Recurrent, Potentially Platinum-Sensitive Ovarian Cancer: A Gynecologic Oncology Group Study
pp. 112-115(4)
Authors: Markman M.; Blessing J.A.; Alvarez R.D.; Hanjani P.; Waggoner S.; Hall K.

Radiation Therapy for Elderly Patient with Squamous Cell Carcinoma of the Uterine Cervix
pp. 116-120(5)
Authors: Sakurai H.; Mitsuhashi N.; Takahashi M.; Yamakawa M.; Akimoto T.; Hayakawa K.; Niibe H.

Establishment and Characterization of a Breast Cell Strain Containing a BRCA1 185delAG Mutation
pp. 121-128(8)
Authors: Annab L.A.; Terry L.; Cable P.L.A.; Brady J.; Stampfer M.R.; Barrett J.C.; Afshari C.A.

The Possible Role of p53 and bcl-2 Expression in Cervical Carcinomas and Their Premalignant Lesions
pp. 129-136(8)
Authors: Dimitrakakis C.; Kymionis G.; Diakomanolis E.; Papaspyrou I.; Rodolakis A.; Arzimanoglou I.; Leandros E.; Michalas S.

Development and Assessment of a General Theory of Cervical Carcinogenesis Utilizing a Severe Combined Immunodeficiency Murine–Human Xenograft Model
pp. 137-148(12)
Authors: Tewari K.S.; Taylor J.A.; Liao S.Y.; DiSaia P.J.; Burger R.A.; Monk B.J.; Hughes C.C.W.; Villarreal L.P.

Use of Hormone Replacement Therapy and Adenocarcinomas and Squamous Cell Carcinomas of the Uterine Cervix
pp. 149-154(6)
Authors: Lacey J.V.; Brinton L.A.; Barnes W.A.; Gravitt P.E.; Greenberg M.D.; Hadjimichael O.C.; McGowan L.; Mortel R.; Schwartz P.E.; Kurman R.J.; Hildesheim A.

Radical Hysterectomy: An Anatomic Evaluation of Parametrial Dissection
pp. 155-163(9)
Authors: Yabuki Y.; Asamoto A.; Hoshiba T.; Nishimoto H.; Nishikawa Y.; Nakajima T.

Can Initial Serum Cyfra 21-1, SCC Antigen, and TPA Levels in Squamous Cell Cervical Cancer Predict Lymph Node Metastases or Prognosis?
pp. 164-170(7)
Authors: Gaarenstroom K.N.; Kenter G.G.; Bonfrer J.M.G.; Korse C.M.; Van de Vijver M.J.; Fleuren G-J.; Trimbos J.B.

Allelic Imbalance in Lichen Sclerosus, Hyperplasia, and Intraepithelial Neoplasia of the Vulva
pp. 171-176(6)
Authors: Pinto A.P.; Lin M-c.; Sheets E.E.; Muto M.G.; Sun D.; Crum C.P.

RU486 Increases Radiosensitivity and Restores Apoptosis through Modulation of HPV E6/E7 in Dexamethasone-Treated Cervical Carcinoma Cells
pp. 177-182(6)
Authors: Kamradt M.C.; Mohideen N.; Vaughan A.T.M.

Paget's Disease of the Vulva: Pathology, Pattern of Involvement, and Prognosis
pp. 183-189(7)
Authors: Parker L.P.; Parker J.R.; Bodurka-Bevers D.; Deavers M.; Bevers M.W.; Shen-Gunther J.; Gershenson D.M.

Alternative Medicine in Gynecologic Oncology: A Case Report
pp. 190-192(3)
Authors: von Gruenigen V.E.; Hopkins M.P.

High-Dose-Rate Interstitial Brachytherapy of Bartholin's Gland: A Case Report
pp. 193-196(4)
Authors: Yamada T.; Yanagawa S.; Iwai H.; Ishigaki T.; Nawa A.; Kikkawa F.

Complete Hydatidiform Mole and a Coexistent Viable Fetus: Report of Two Cases and Review of the Literature
pp. 197-202(6)
Authors: Bruchim I.; Kidron D.; Amiel A.; Altaras M.; Fejgin M.D.

-Fetoprotein Production by a Malignant Mixed Müllerian Tumor of the Ovary
pp. 203-205(3)
Authors: Rebischung C.; Pautier P.; Morice P.; Lhomme C.; Duvillard P.

Metachronous Carcinoma of the Vulva and Fallopian Tube
pp. 206-209(4)
Authors: Ichikawa Y.; Tsunoda H.; Nishide K.; Nishida M.; Kubo T.

Recurrent Rectoneovaginal Fistula Caused by an Incidental Squamous Cell Carcinoma of the Neovagina in Mayer–Rokitansky–Küster–Hauser Syndrome
pp. 210-212(3)
Authors: Schult M.; Hecker A.; Lellé R.J.; Senninger N.; Winde G.

Successful Preservation of Fertility Subsequent to a Complete Pathologic Response of a Squamous Cell Carcinoma of the Uterine Cervix Treated with Primary Systemic Chemotherapy
pp. 213-215(3)
Authors: Andrade J.M.; Marana H.R.C.; Mangieri L.F.; Matthes Â.C.S.; Cunha S.P.; Bighetti S.

Uterine Metastasis from a Heterologous Metaplastic Breast Carcinoma Simulating a Primary Uterine Malignancy
pp. 216-218(3)
Authors: Sinkre P.; Milchgrub S.; Miller D.S.; Albores-Saavedra J.; Hameed A.

Choroidal Metastasis Presented as the Initial Symptom of the Recurrence from Ovarian Endometrioid Adenocarcinoma: A Case Report
pp. 219-221(3)
Authors: Akahira J-i.; Konno R.; Ito K.; Sato S.; Yajima A.

Volume 76, Number 2 (2000), in “Abstracts Presented for the Thirty-First Annual Meeting of the Society of Gynecologic Oncologists,” pages 230–284 (doi:10.1006/gyno.1999.5695)
pp. 222-222(1)

Papers to Appear in Forthcoming Issues
pp. 223-223(1)